BRISBANE, Calif., Oct. 19, 2016 -- Cutera, Inc. (NASDAQ:CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, announced today that Ronald J. Santilli, Interim Chief Executive Officer and Chief Financial Officer, will be presenting at the 2016 Sidoti Emerging Growth Convention and the Canaccord Genuity Medical Technology and Diagnostics Forum in November.
2016 Sidoti Emerging Growth Convention
Date: Tuesday, November 1st
Time: 3:35 PM ET
Location: New York Marriott Marquis at Times Square, New York, NY
Canaccord Genuity Medical Technology and Diagnostics Forum
Date: Thursday, November 17th
Time: 8:00 AM ET
Location: Westin Grand Central, New York, NY
Both presentations will be available for review on the Investor Relations section of the Company's website at www.cutera.com.
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
CONTACTS: Cutera, Inc. Ron Santilli Interim Chief Executive Officer and Chief Financial Officer [email protected] Investor Relations John Mills Integrated Corporate Relations, Inc. [email protected]


Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Italy Fines Apple €98.6 Million Over App Store Dominance
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 



